An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Alnylam to Webcast Presentations at Upcoming March Investor Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Alnylam Pharmaceuticals (Nasdaq: ALNY) announced its participation in several upcoming healthcare conferences. Management will present at the Cowen 43rd Annual Health Care Conference on March 8, 2023, at 2:10 pm ET in Boston, the Oppenheimer 33rd Annual Healthcare Conference on March 15, 2023, at 1:20 pm ET virtually, the Barclays Global Healthcare Conference on March 16, 2023, at 8:00 am ET in Miami, and the Stifel 2023 CNS Days on March 29, 2023, at 9:30 am ET virtually. Live webcasts will be accessible on the Investors section of Alnylam's website, with replays available within 48 hours of each event.
Positive
None.
Negative
None.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present company overviews at the following conferences:
Cowen 43rd Annual Health Care Conference on Wednesday, March 8, 2023 at 2:10 pm ET at the Boston Marriott Copley Place
Oppenheimer 33rd Annual Healthcare Conference on Wednesday, March 15, 2023 at 1:20 pm ET being held virtually
Barclays Global Healthcare Conference on Thursday, March 16, 2023 at 8:00 am ET at the Loews Miami Beach Hotel
Stifel 2023 CNS Days on Wednesday, March 29, 2023 at 9:30 am ET being held virtually
A live audio webcast of each presentation will be available on the Investors section of the Company’s website at www.alnylam.com/events. A replay will be available on the Alnylam website within 48 hours after each event.
About Alnylam Pharmaceuticals Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and prevalent diseases with unmet need. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach yielding transformative medicines. Since its founding 20 years ago, Alnylam has led the RNAi Revolution and continues to deliver on a bold vision to turn scientific possibility into reality. Alnylam’s commercial RNAi therapeutic products are ONPATTRO® (patisiran), AMVUTTRA® (vutrisiran), GIVLAARI® (givosiran), OXLUMO® (lumasiran), and Leqvio® (inclisiran), which is being developed and commercialized by Alnylam’s partner, Novartis. Alnylam has a deep pipeline of investigational medicines, including multiple product candidates that are in late-stage development. Alnylam is executing on its “Alnylam P5x25” strategy to deliver transformative medicines in both rare and common diseases benefiting patients around the world through sustainable innovation and exceptional financial performance, resulting in a leading biotech profile. Alnylam is headquartered in Cambridge, MA. For more information about our people, science and pipeline, please visit www.alnylam.com and engage with us on Twitter at @Alnylam, on LinkedIn, or on Instagram.
Alnylam Pharmaceuticals, Inc. Christine Regan Lindenboom (Investors and Media)
617-682-4340
Josh Brodsky (Investors)
617-551-8276
Source: Alnylam Pharmaceuticals, Inc.
FAQ
What conferences will Alnylam Pharmaceuticals present at in March 2023?
Alnylam Pharmaceuticals will present at the Cowen 43rd Annual Health Care Conference on March 8, the Oppenheimer 33rd Annual Healthcare Conference on March 15, the Barclays Global Healthcare Conference on March 16, and the Stifel 2023 CNS Days on March 29, 2023.
When is Alnylam's presentation at the Cowen 43rd Annual Health Care Conference?
Alnylam's presentation at the Cowen 43rd Annual Health Care Conference is scheduled for March 8, 2023, at 2:10 pm ET.
Will there be a webcast for Alnylam's conference presentations?
Yes, live audio webcasts of Alnylam's conference presentations will be available on the Investors section of their website.
What time is Alnylam presenting at the Oppenheimer 33rd Annual Healthcare Conference?
Alnylam will present at the Oppenheimer 33rd Annual Healthcare Conference on March 15, 2023, at 1:20 pm ET.
Where can I find replays of Alnylam’s conference presentations?
Replays of Alnylam's conference presentations will be available on their website within 48 hours after each event.
